Updated Oct 9, 2026 · 04:30 UTC
ABBVAbbVie Inc
Health Care · United States · XNYS · pharmaceutical preparations
$271.68+0.39%last session · market closed
Market cap
$480.09b
real-world
Tokenized
$277k
<0.001% of the asset
Avg token price
$280.04
+3.08% vs real
Spot volume, 24h
$222k
6 venues
Derivatives, 24h
—
Perp open interest
—
In DeFi
—
ABBV · Price
Sep 19, 2025low $197.72 · high $275.78 · now $273.25Oct 7, 2026
Token Real
Earnings
Nasdaq’s earnings calendar
Next earnings
Oct 30
before the open · Sep 2026 quarter · EPS forecast $3.77 (2 analysts)
Last earnings, Jul 31
$3.65 EPS
+0.3% vs $3.64 forecast · Jun 2026 quarter
Real market
ABBVIE INC.
Last close
$271.36
Oct 7
Traded on Oct 7
$1.65b
Price now
$271.68
market closed
Where it trades
24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals
Spot · $222k · 6 venues
Blynex1 pair$132k
XT.COM1 pair$63k
Gate1 pair$26kDerivatives · — · 0 venues
None yet
Onchain versions
3 tokens from 2 issuers
ABBVXBacked Assets$272.11$270k
ABBVonOndo Assets$285.57$7k
WABBVXBacked Assets——By chain
Where the tokens circulate, issuers’ unsold stock taken off
Solana46%$128k
TON45%$126k
Ethereum4.4%$12k
Ink2.9%$8k
BNB Chain0.9%$3kIn DeFi
Pools and lending markets that hold these tokens
None found
Business 12 months to Jun 2026 · SEC EDGAR
Results
Revenue
$64.39b
+10% YoY
Operating income
$16.87b
26% margin · +54% YoY
Net income
$6.31b
10% margin · +68% YoY
EPS, diluted
$3.56
+68% YoY
Net income is $10.56b below operating income. The difference lies outside operations (gains or losses on investments, interest) and in tax; operating income is the closer read of the business itself.
Cash and balance sheet
Free cash flow
$18.21b
28% of revenue
Net debt
$55.91b
$6.57b cash and securities, $62.48b debt
Diluted shares
1.77b
+0% YoY
Valuation at today’s market cap
P/E
76×
EV / sales
8.3×
enterprise value $536.00b
EV / operating income
31.8×
Free cash flow yield
3.8%
Quarterly
RevenueNet income